- Home
- / Laboratorios Richmond
Laboratorios Richmond
Stock Price
$1.7 K
2024-10-29
Market Capitalization
$133.2 B
2024-10-29
Revenue
$126.7 B
FY, 2025
Laboratorios Richmond Summary
Company Summary
- Overview
- Laboratorios Richmond is a company that manufactures pharmaceutical products. It offers oncology, oncohematology, anti-platelet, psychiatric, and hypnotic drugs and medicines for the treatment of HIV, HCV, and multiple sclerosis.
- Type
- Public
- Status
- Active
- Founded
- 1935
- HQ
- Buenos Aires, AR | view all locations
- Website
- https://ir.richmondlab.com/
Table of Contents
Key People
Arturo Berger, Director of Operations
Pablo Da Pos, Technical Director, Quality and Compliance Manager
Maximiliano Bergman, Medical Director
LocationsView all
3 locations detected
Buenos Aires, Cdad. Autónoma de Buenos Aires HQ
Argentina
Bouchard 680
Buenos Aires, Cdad. Autónoma de Buenos Aires
Argentina
Av. Elcano 4938
Fatima, Provincia de Buenos Aires
Argentina
Calle 3, 517
Laboratorios Richmond Financials
Summary Financials
- Revenue (FY, 2025)
- $126.7B
- Gross profit (FY, 2025)
- $80.4B
- Net income (FY, 2025)
- $2.1B
- Cash (FY, 2025)
- $10.8B
- EBIT (FY, 2025)
- $32.8B
- Enterprise value
- $348.1B